Penumbra, Inc. IPO Research Information

Penumbra, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Penumbra, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Penumbra, Inc.	PEN - NYSE	$25.00-$28.00	$30.00	$40.00	4 million	9/18/2015
Underwriter(s): J.P. Morgan, BofA Merrill Lynch
Co-Manager(s): Wells Fargo Securities, Canaccord Genuity
Industry: Health Care
Filing(s): Filed 2015-08-14 Terms Added 2015-09-08

Penumbra, Inc. Quote & Chart - Click for current quote - PEN

About Penumbra, Inc. (adapted from Penumbra, Inc. prospectus):
Penumbra is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "PEN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.